Endovascular Modalites for Contralateral Common Iliac Artery in Patients With Symptomatic Unilateral Common Iliac Artery Occlusive Disease

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07012551

Enrollment

Registered

2025-06-10

Start date

2025-08-01

Completion date

2027-05-01

Last updated

2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iliac Artery Disease

Brief summary

To evaluate the safety, efficacy, and outcomes of endovascular strategies for protection of the contralateral CIA in patients with symptomatic unilateral CIA occlusive disease

Interventions

PROCEDURECommon iliac artery stenting

Stenting of common iliac artery by balloon mounted stent

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Symptomatic patients (Rutherford category 3- 5) due to Unilateral common iliac artery occlusive disease. with or without combined iliac or femoropopliteal or infrapopliteal lesions. Asymptomatic Contralateral limb. Patent at least one run-off vessel

Exclusion criteria

* Distal aorta lesion contralateral CIA occlusion Previous endovascular or surgical procedures for the same lesion Hypersensitivity to contrast material Presence of aortic or iliac aneurysms Patients with unsalvageable limb Non atherosclerotic lesions

Design outcomes

Primary

Measure	Time frame
Primary patency of both common iliac arteries	2 years

Contacts

Primary Contactabdelrahman eltokhey

abdelrahmaneltokhey11@gmail.com01003830585

Backup Contactmahmoud ismail

mahmoudismail79@yahoo.com0106228283

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026